Here are relevant reports on : breast-implants-market
-
Global Breast Cancer Drugs Market
There are about one million new cases of breast cancer every year. Breast cancer accounts for about 10% of world wide cancer. There has been significant increase in awareness levels with respect to impact on survival rates incase of early diagnosis. Therefore, opening novel opportunities for breast cancer drugs market.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Global Biological Implants Market (2011-2016)
Biological Implants find enormous application in the fields of neurological, cardiovascular, vascular, urogenital, nephrological and orthopedic systems. They are used to treat various disorders of the above systems. Biological Implants are expected to increase productivity by identifying potential biological substitutes for the body’s repairable parts. Currently United States serves as the largest market for these biological implants. The biological implants market is segmented by Tissue/Muscle into Soft Tissue, Orthopedic, Cardiovascular, Other (includes Dental, Ophthalmic, and Urologic). By Origin these implants are segmented as Allograft and Xenograft, and by Mode of Administration into Injectable and Surgical.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Global Dental Implants Market (2010 -2015)
The global dental implants market is estimated to be $ 4 billion by 2014, growing at a CAGR of 6 %.this is the most promising and dynamic market within dental device market with 18% of market share. The market is expected to grow because of the tremendous demand for cosmetic dentistry and effective treatment for edentulism. The European and North American markets are the top two markets with most promising outlook for the future. The developing economies in Asian and South American regions are also expected to contribute to the growth of the market in the coming years.
- Published: July 2010
- Price: $ 4950
- TOC Available:
-
Brain Implants Market - Global Forecast to 2024
Brain implants (also referred as neuroprosthetics or neural implants) are technological devices that attach directly to a biological subject’s brain – generally placed on the surface of the brain or attached to the brain’s cortex. Growing ageing population and subsequent rise in incidences of neurological disorders such as Parkinson’s, Alzheimer’s, epilepsy, depression, and essential tremors, increasing health awareness, and technological innovations are some of the key factors driving the growth of the market. According to the WHO, an estimated 2.4 million people are diagnosed with epilepsy each year worldwide. Moreover, according to European Brain Council, globally, it is estimated that 6.3 million people affected with Parkinson’s disease in 2016. However, the high cost of brain implant devices and procedures may limit the brain implants market up to some extent.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Memory Implants Market, By Products, Technology, Application & Geography – 2018
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Anatomic Pathology Market by Product [Consumables (Histopathology, Cytopathology), Instruments, Software], Process, Disease (Breast, GI, Prostate), End User (Hospitals, Research Labs), Services, Model (In House, Outsourced) – Global Forecast to 2031
The global anatomic pathology market is projected to reach USD 14.5 billion by 2031, growing at a CAGR of 10.2% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Companion Diagnostics Market by Product (Assays, Kits, & Reagents, Instruments, Software), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Lung, Colorectal Cancer, CVD, Infectious), Drug Class (MAB, Cell & Gene Therapy) - Global Forecast to 2031
The global companion diagnostics market is projected to reach USD 11.57 billion by 2031, growing at a CAGR of 12.9% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Breast Cancer Liquid Biopsy Market by Circulating Biomarkers, Region, End User, Investments, Market Dynamics, Platform Comparison (NGS, PCR), Competitive Landscape (Acquisition, Mergers, Collaboration, Competitive technology) & Geography
The global breast cancer liquid biopsy market is projected to grow at a CAGR of 23.1%. Factors such as increasing prevalence of breast cancer, increasing preference for noninvasive procedures, initiatives undertaken by government and global health organizations, technological advancements to augment market revenues, rising emphasis on personalized medicine in clinical practice, and increased funding for liquid biopsy R&D are driving the growth of the breast cancer liquid biopsy market. The key players in the global breast cancer liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US).
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
Contract Research Organization (CRO) Services Market by Type (Early Phase, Clinical, Lab, Consulting), Therapeutic Area [Oncology (Breast, Lung), Infectious, Neurology, Vaccines], Modality, Model (FSO, FSP), End User, Competition - Global Forecast to 2031
The global contract research organization services market is projected to reach USD 140.32 billion by 2031, growing at a CAGR of 8.6% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 7150
- TOC Available:
-
Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023
The global oncology nutrition market is expected to reach USD 2.21 Billion by 2023 from USD 1.46 Billion in 2018, at a CAGR of 8.7%. Factors such as shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions are driving the market growth. The prominent players in the oncology nutrition market are Abbott Laboratories (US), Nestle S.A. (Switzerland), Danone (France), Fresenius Kabi AG (Germany), and B. Braun Melsungen AG (Germany).
- Published: April 2018
- Price: $ 16000
- TOC Available:
Records 11 to 20 of 50
